Welltower shares climbed sharply in after-hours trading following the company’s release of second-quarter 2026 results after the market close. Revenue for the period came in at $3.54 billion, outperforming the Wall Street consensus of $3.36 billion and representing a 39.1% increase from the comparable quarter a year earlier.
Normalized funds from operations (FFO) were $1.60 per diluted share, narrowly underperforming the analyst consensus of $1.66. While the normalized FFO fell short of expectations, the magnitude of the top-line beat appeared sufficient to sustain investor enthusiasm.
Analyst action and market reaction
On the same day as the earnings release, Mizuho raised its price target on the stock to $260 from $239, a move that coincided with the after-hours rally. Earlier in the month, UBS also lifted its target to $271. The shares carried a "Strong Buy" consensus rating across Wall Street at the time of the report.
The company’s seniors housing operating portfolio was highlighted as the primary growth driver, continuing to benefit from demographic dynamics and limited new supply in the market.
Company-specific momentum amid muted broader markets
The broader U.S. equity market offered little lift on the day: the S&P 500 was essentially flat at +0.04%, the Dow Jones edged up 0.01%, and the Nasdaq gained 0.06%. That limited movement in major indices underscored that Welltower’s after-hours advance was driven largely by firm-specific developments rather than a sector-wide rebound. Peer healthcare REITs such as Ventas and Healthpeak did not report major earnings today, reducing the likelihood of a broader sector push.
The shares exceeded their prior 52-week high of $252.94 and reached $258.95 in after-hours trading, reflecting strong investor response to the results. Market data also showed a regular-session close at $248.34 and an after-hours quote near $258.30.
What this means
The combination of a sizable revenue beat, a same-day analyst price target upgrade, and an established record of outperforming FFO expectations appears to have driven the stock higher in after-hours trading. Investors reacted to the scale of the top-line outperformance and to renewed analyst conviction about the company’s trajectory.